Challenges That Hinder the Translation of Clinical Advances Into Practice: Results From an International Assessment in Colorectal Cancer

Clinical Colorectal Cancer
Patrice LazureSuzanne Murray

Abstract

Over the past decade, individualization of treatment for colorectal cancer (CRC) has been improved by: (1) approval of several new agents by national agencies such as the US Food and Drug Administration (FDA); and (2) rapid advances in mutation analysis. However, data are sparse on the clinical challenges experienced by oncologists as they address the increased complexity created by the growing potential for individualization of CRC treatment. To identify clinical challenges experienced by oncologists regarding CRC treatment, an international assessment was conducted. A mixed methods approach was used, with the collection and analysis of qualitative (semistructured telephone interviews) and quantitative (online survey) data. Participants were oncologists actively practicing in 1 of 7 targeted countries with a minimum caseload of 10 CRC patients per year. The sample included 358 oncologists from China (n = 68), France (n = 44), Germany (n = 44), Italy (n = 45), Spain (n = 44), the United Kingdom (n = 45), and the United States (n = 68). Mixed methods findings indicated that oncologists' treatment selection is hindered by practice challenges in: (1) mutation analysis and subsequent adaptation of treatment; (2) optimal sequential ...Continue Reading

References

Jan 27, 2004·Education for Health : Change in Training & Practice·K J Devers, R M Frankel
Oct 6, 2005·Qualitative Health Research·Hsiu-Fang Hsieh, Sarah E Shannon
Feb 10, 2011·Genes, Chromosomes & Cancer·Cecily P VaughnWade S Samowitz
Jul 7, 2011·Clinical Colorectal Cancer·Leticia De Mattos-ArrudaJosep Tabernero
Sep 20, 2012·Journal of Cellular Biochemistry·Nicola NormannoAntonella De Luca
Nov 21, 2012·The Journal of Pathology·Enric DomingoIan Tomlinson
Jan 9, 2013·Nature Reviews. Clinical Oncology·Mariana Chavez-MacGregor, Ana Maria Gonzalez-Angulo
May 15, 2013·The Oncologist·Axel S MerseburgerUNKNOWN European Treatment Practices Group
Jul 9, 2013·Clinica Chimica Acta; International Journal of Clinical Chemistry·Brian C Netzel, Stefan K G Grebe
Aug 8, 2013·The American Journal of Pathology·Francine B De AbreuGregory J Tsongalis
Aug 13, 2013·Thoracic Surgery Clinics·Shobha Silva, Sarah Danson
Aug 27, 2013·Lancet·Rafael RosellNiki Karachaliou
Sep 12, 2013·Journal of Clinical Pathology·Umberto MalapelleGiancarlo Troncone
Sep 13, 2013·The New England Journal of Medicine·Jean-Yves DouillardScott D Patterson
Sep 13, 2013·The New England Journal of Medicine·Jordan Berlin
Oct 1, 2013·The Breast : Official Journal of the European Society of Mastology·Matthew J Ellis

❮ Previous
Next ❯

Citations

Sep 15, 2018·Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology·Suzanne MurraySusan Waserman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.